Azienda Ospedaliero Universitaria Maggiore della Carita
74
14
15
36
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.4%
1 terminated/withdrawn out of 74 trials
97.3%
+10.8% vs industry average
9%
7 trials in Phase 3/4
6%
2 of 36 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (74)
Patient Satisfaction Study at AOU Maggiore Della Carità (SCORE)
Role: collaborator
A Nurse-led Coaching Programme With Telemonitoring in Heart Failure
Role: collaborator
Personalized Risk Stratification Model of Follicular Lymphoma Patients
Role: collaborator
prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia
Role: collaborator
Retinal and Cognitive Dysfunction in Type 2 Diabetes
Role: collaborator
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
Role: lead
Oral Health and Fundamental of Care Program
Role: collaborator
T1DM Clinical Onset and Progression in Paediatric Population
Role: collaborator
Microparticles Blood Level in Acute Carbon Monoxide Poisoning
Role: lead
The ROTAtional-USE of Interface STUDY
Role: lead
Effects of VLCKD in Metabolic Syndrome
Role: lead
Rapamycin Treatment for ALS
Role: collaborator
ZIMBA: Clinical Trial in Paediatric Obesity
Role: lead
NON-COlorectal Liver METastases Undergoing Liver Resection
Role: lead
Bimbingamba Zerosix Third Phase: Studying Communities
Role: lead
Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
Role: lead
PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry
Role: collaborator
Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine
Role: lead
Monitoring of Lung Ventilation Through Electrical Impedance Tomography During Pediatric Surgery
Role: lead
Dietary Fructose: a Metabolic Switch in Pediatric Obesity-related Disease.
Role: lead